The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene label mismatch: MTM1 vs undefined
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • No CSPEC computed assertion could be determined for this classification!


Variant: NM_000252.3(MTM1):c.1210G>A (p.Glu404Lys)

CA10539219

530855 (ClinVar)

Gene: MTM1
Condition: centronuclear myopathy
Inheritance Mode: X-linked inheritance
UUID: 4555c90b-b9d2-4159-a35d-5cd69bc61fee
Approved on: 2025-02-20
Published on: 2025-03-27

HGVS expressions

NM_000252.3:c.1210G>A
NM_000252.3(MTM1):c.1210G>A (p.Glu404Lys)
NC_000023.11:g.150657977G>A
CM000685.2:g.150657977G>A
NC_000023.10:g.149826450G>A
CM000685.1:g.149826450G>A
NC_000023.9:g.149577108G>A
NG_008199.1:g.94404G>A
ENST00000684910.1:c.*743G>A
ENST00000685439.1:c.865G>A
ENST00000685944.1:c.1210G>A
ENST00000686212.1:n.812G>A
ENST00000687215.1:c.*965G>A
ENST00000688152.1:c.*654G>A
ENST00000688403.1:c.466G>A
ENST00000689314.1:c.1255G>A
ENST00000689694.1:c.1210G>A
ENST00000689810.1:c.*859G>A
ENST00000690282.1:c.466G>A
ENST00000690351.1:c.*862G>A
ENST00000691232.1:c.865G>A
ENST00000691482.1:n.2225G>A
ENST00000691686.1:c.1210G>A
ENST00000691851.1:c.1053+8076G>A
ENST00000692015.1:c.997G>A
ENST00000692638.1:c.*1015G>A
ENST00000692852.1:c.1021G>A
ENST00000692915.1:c.*1356G>A
ENST00000370396.7:c.1210G>A
ENST00000306167.11:n.1077G>A
ENST00000370396.6:c.1210G>A
NM_000252.2:c.1210G>A
NM_001376906.1:c.1210G>A
NM_001376907.1:c.1099G>A
NM_001376908.1:c.1210G>A
More

Pathogenic

Met criteria codes 6
PP4 PP1 PP3 PS4_Very Strong PM2_Supporting PS3_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Congenital Myopathies Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for MTM1 Version 1.0.0

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Congenital Myopathies VCEP
The NM_000252.3(MTM1):c.1210G>A variant in MTM1 is a missense variant predicted to cause substitution of glutamic acid by lysine at amino acid 404 (p.Glu404Lys). This variant has been reported in 10 probands meeting X-linked centronuclear myopathy (PS4_VeryStrong; PMIDs: 19084976, 33164942, 25957634, 9285787, 38544359, 38259611, 12467749, 30902907, 17005396). At least one patient with this variant displayed muscle biopsy with rounded muscle fibers with a single centrally located nucleus surrounded by a halo devoid of contractile elements, but containing mitochondria, which is highly specific for X-linked centronuclear myopathy (PP4; PMID: 17005396). The variant has been reported to segregate with disease in 4 affected individuals from 2 families (PP1; PMIDs: 17005396, 33164942). The variant is absent from gnomAD v.4.1.0 (PM2_Supporting). Immunofluorescence and western blot assays in COS cells (fibroblast-like cells derived from monkey kidney) showed unstable protein with aggregates in the cytoplasm and near the nucleus, probably in the Golgi, and very low myotubularin levels on western blot, indicating that this variant impacts protein function (PS3_Supporting; PMID: 12118066). The computational predictor REVEL gives a score of 0.759, which is above the threshold of 0.7 evidence that correlates with impact to MTM1 function (PP3). In summary, this variant meets the criteria to be classified as pathogenic for X-linked centronuclear myopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen Congenital Myopathies VCEP: PS4_VeryStrong, PS3_Supporting, PM2_Supporting, PP1, PP3, PP4 (ClinGen Congenital Myopathies VCEP specifications version 1.0.0; 2/20/2025).
Met criteria codes
PP4
At least one patient with this variant displayed muscle biopsy with rounded muscle fibers with a single centrally located nucleus surrounded by a halo devoid of contractile elements, but containing mitochondria, which is highly specific for X-linked centronuclear myopathy (PP4_Supporting, PMIDs 17005396).
PP1
The variant has been reported to segregate with disease in 4 affected individuals from 2 families (PP1_Supporting; PMIDs: 17005396, 33164942)
PP3
The computational predictor REVEL gives a score of 0.759, which is above the threshold of 0.7, evidence that correlates with impact to MTM1 function (PP3_Supporting).
PS4_Very Strong
This variant has been reported in 10 probands meeting X-linked centronuclear myopathy (PS4_Strong; PMIDs: 19084976, 33164942, 25957634, 9285787, 38544359, 38259611, 12467749, 30902907, 17005396).
PM2_Supporting
The variant is absent from gnomAD v.4.1.0. (PM2_Supporting).
PS3_Supporting
Immunofluorescence and western blot assays in COS cells (fibroblast-like cells derived from monkey kidney) showed unstable protein with aggregates in the cytoplasm and near the nucleus, probably in the Golgi, and very low myotubularin levels on western blot (data not shown) indicating that this variant impacts protein function (PMID 12118066)(PS3_Supporting).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.